Stryker Corporation $SYK Stake Lifted by Nisa Investment Advisors LLC

Key Points

• Nisa Investment Advisors increased its Stryker stake by 5.1% in the third quarter, bringing its holdings to 100,808 shares valued at approximately $27.85 million. Institutional investors collectively own 77.09% of the company.
• Stryker reported quarterly earnings of $3.69 per share, topping estimates of $3.49, while revenue rose 9.4% year over year to $6.59 billion. The company also declared a quarterly dividend of $0.88 per share, yielding about 1.2% annually.
• Analyst sentiment remains generally positive, with a consensus “Moderate Buy” rating and an average price target of $369, although some firms recently lowered targets or downgraded the stock. Insiders sold roughly $118.2 million worth of shares over the past three months.

Nisa Investment Advisors LLC lifted its stake in shares of Stryker Corporation (NYSE:SYK - Free Report) by 5.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 100,808 shares of the medical technology company's stock after acquiring an additional 4,864 shares during the quarter. Nisa Investment Advisors LLC's holdings in Stryker were worth $27,850,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Oregon Pacific Wealth Management LLC increased its position in shares of Stryker by 27.0% during the 3rd quarter. Oregon Pacific Wealth Management LLC now owns 922 shares of the medical technology company's stock valued at $254,000 after purchasing an additional 196 shares during the period. Diversify Advisory Services LLC raised its stake in shares of Stryker by 11.6% in the 3rd quarter. Diversify Advisory Services LLC now owns 19,274 shares of the medical technology company's stock worth $5,652,000 after buying an additional 1,999 shares in the last quarter. Lakeshore Capital Group Inc. raised its stake in shares of Stryker by 10.8% in the 3rd quarter. Lakeshore Capital Group Inc. now owns 2,809 shares of the medical technology company's stock worth $773,000 after buying an additional 274 shares in the last quarter. QV Investors Inc. acquired a new stake in shares of Stryker in the third quarter valued at $8,901,000. Finally, Miller Financial Services LLC lifted its holdings in shares of Stryker by 12.7% in the third quarter. Miller Financial Services LLC now owns 2,720 shares of the medical technology company's stock valued at $749,000 after buying an additional 306 shares during the period. Institutional investors own 77.09% of the company's stock.

Stryker Trading Up 2.2%

Stryker stock opened at $304.59 on Wednesday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The firm has a market cap of $116.83 billion, a price-to-earnings ratio of 31.56, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. Stryker Corporation has a 1 year low of $267.00 and a 1 year high of $392.55. The firm's 50 day moving average price is $297.53 and its two-hundred day moving average price is $312.37.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The company had revenue of $6.59 billion for the quarter, compared to analysts' expectations of $6.58 billion. During the same quarter in the prior year, the company earned $3.13 earnings per share. The firm's revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, research analysts predict that Stryker Corporation will post 14.93 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Wednesday, September 30th. Stryker's payout ratio is presently 36.48%.

Insider Transactions at Stryker

In other news, insider Debra King sold 826 shares of the business's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider directly owned 6,210 shares of the company's stock, valued at $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Ronda Stryker sold 50,000 shares of the company's stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total value of $17,005,000.00. Following the sale, the director directly owned 2,251,375 shares of the company's stock, valued at approximately $765,692,637.50. This represents a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 351,267 shares of company stock valued at $118,197,701 over the last three months. Company insiders own 4.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Truist Financial decreased their target price on Stryker from $340.00 to $310.00 and set a "hold" rating for the company in a research note on Tuesday, October 6th. Canaccord Genuity Group dropped their price target on shares of Stryker from $400.00 to $385.00 and set a "buy" rating on the stock in a research report on Friday, September 18th. Sanford C. Bernstein reiterated a "market perform" rating on shares of Stryker in a research report on Wednesday, October 7th. Barclays raised shares of Stryker to a "strong-buy" rating in a report on Wednesday, October 7th. Finally, Wall Street Zen lowered shares of Stryker from a "buy" rating to a "hold" rating in a research report on Saturday, October 3rd. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $369.00.

Stryker Company Profile

Stryker Corporation NYSE: SYK is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company's product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.